Genome editing has advanced at a rapid pace with promising results for treating genetic conditions -- but there is always room for improvement. A new paper showcases the power of scalable protein ...

An expert panel will discuss the latest research on CRISPR and how to use it in biotechnology and disease research.

Genome editing has advanced at a rapid pace with promising results for treating genetic conditions—but there is always room ...

Bristol Myers Squibb’s new treatment for schizophrenia didn’t provide additional benefits to patients when given on top of ...

Scientists at the VIB-UGent Center for Plant Systems Biology and VIVES University College have developed a new method to genetically improve poplar trees without introducing foreign DNA into its ...

Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...

In “Second Life,” the journalist Amanda Hess navigates the stratified landscape of contemporary reproductive technology.

What are NGTs, how do they differ from GMOs and how are they agriculturally applied and regulated in the EU? View on euronews ...

The researchers analyzed changes to gene expression in ecDNA formed by HPV and human DNA hybridization in oropharyngeal tumor ...

Learn about Brink Therapeutics as it raises $4 million to go beyond CRISPR with engineered recombinases in CAR T therapy.

The Food and Drug Administration has approved the world’s first medicine based on CRISPR gene-editing technology, a ...

Learn more about whether Amarin Corporation plc or CRISPR Therapeutics AG is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.